Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these ...
Meanwhile, ADX-097 provides localized inhibition of the complement system to manage immune-mediated kidney diseases, including lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA ...
The burden of chronic lymphocytic leukemia (CLL) in the prognosis of solid organ transplant (SOT) recipients seems non-negligible. Whether transplanting a patient with previous CLL is safe or what is ...
BCX-10013 is under clinical development by BioCryst Pharmaceuticals and currently in Phase I for Paroxysmal Nocturnal Hemoglobinuria. According to GlobalData, Phase I drugs for Paroxysmal Nocturnal ...
Thrombotic microangiopathy (TMA) is a rare renal complication of patients with chronic lymphocytic leukemia (CLL) and is often associated with peripheral features. We present the first case of CLL ...
When you have complement 3 (C3) glomerulopathy, a problem with your immune system can damage your kidneys. You’ll take medicine to control your immune system and protect your kidneys.
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...